Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Vilaprinyo, Ester ^a,b   Forné, Carles ^a,b   Carles, Misericordia ^c   Sala, Maria ^d,e,g   Pla, Roger ^c,f   Castells, Xavier ^d,e,g   Domingo, Laia ^d,g   Rue, Montserrat ^a,b,e   Blanch, Jordi ^g   Comas, Mercè ^g   Macià, Francesc ^g   Martínez, Juan ^g   Rodríguez Arana, Ana ^g   Román, Marta ^g   Romero, Anabel ^g   Alberich, Carmen ^h   Casals, María ^h   Ibáñez, Josefa ^h   Lluch, Amparo ^h   Martínez, Inmaculada ^h   Miranda, Josefa ^h   Morales, Javier ^h   Salas, Dolores ^h   Torrella, Ana ^h   Almazán, Raquel ⁱ   Conde, Miguel ⁱ   Corujo, Montserrat ⁱ   Fernández, Ana Belén ⁱ   Mosquera, Joaquín ⁱ   Sarandeses, Alicia ⁱ   Vázquez, Manuel ⁱ   Zubizarreta, Raquel ⁱ   Barata, Teresa ^j   Díez De La Lastra, Isabel ^j   Reyes, Juana María ^j   Otegi, Arantza ^k   Sarriugarte, Garbiñe ^k   Baré, Marisa ^l   Torà, Núria ^l   Ferrer, Joana ^m   Castanyer, Francesc ^m   Renart, Gemma ^m   Marcos Gragera, Rafael ⁿ   Puig Vives, Montserrat ⁿ   Martínez Alonso, Montserrat ^b   Roso, Albert ^b   Gregori, Aleix ^c   Pérez, María José ^c   more..

^a UNIVERSITY OF LLEIDA   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^e Health Services Research Network in Chronic Diseases (REDISSEC)   (Spain)

^f H Joan XXIII   (Spain)

^g HOSPITAL DEL MAR   (Spain)

^h Gerencia FISABIO   (Spain)

ⁱ Public Health and Planning Directorate   (Spain)

^j Canary Islands Health Service   (Spain)

^k BasqueCountry Breast Cancer Screening Programme   (Spain)

^l Hospital Universitari Parc Taulí   (Spain)

^m HOSPITAL SANTA CATERINA   (Spain)

ⁿ UNIVERSITY OF GIRONA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER RISK; CANCER SCREENING; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ERROR; ECONOMIC EVALUATION; FALSE POSITIVE RESULT; FAMILY HISTORY; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; ONSET AGE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; MASS SCREENING; MIDDLE AGED; PROCEDURES; QUALITY ADJUSTED LIFE YEAR; REGISTER; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPAIN; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; MODELS, ECONOMIC; QUALITY-ADJUSTED LIFE YEARS; REGISTRIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPAIN;

EID: 84895477166     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086858     Document Type: Article

References (51)

1. Feuer E, Plevritis SK, Berry DA, Cronin KA (eds), et al. (2006) The impact of mammography and adjuvant therapy on US breast cancer mortality (1975-2000): collective results from the Cancer Intervention and Surveillance modeling network. J Natl Cancer Inst Monogr (36): 1-126.
2. Roman R, Sala M, Salas D, Ascunce N, Zubizarreta R, et al. (2011) Effect of protocol-related variables and women's characteristics on the cumulative false-positive risk in breast cancer screening. Ann Oncol 23: 104-111.
3. Kalager M, Adami HO, Bretthauer M, Tamimi RM (2012) Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 156: 491-499.
4. Jorgensen KJ, Gotzsche PC (2009) Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 339: b2587.
5. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, et al. (2009) Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 151: 738-747.
6. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, et al. (2008) European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition-summary document. Ann Oncol 19: 614-22. (Pubitemid 351461029)
7. Joy J, Penhoet E, Petitti D, editors, Institute of Medicine and National Research Council Committee on new approaches to early detection and diagnosis of breast cancer (2005) Saving women's lives: strategies for improving breast cancer detection and diagnosis. The National Academies Press, Washington D.C. Available: http://www.ncbi.nlm.nih.gov/books/NBK22315/. Accessed 2013 Dec 21.
8. Schousboe JT, Kerlikowske K, Loh A, Cummings SR (2011) Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med 155: 10-20.
9. van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, et al. (2012) Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med 156: 609-617.
10. Carles M, Vilaprinyo E, Cots F, Gregori A, Pla R, et al. (2011) Cost-effectiveness of early detection of breast cancer in Catalonia (Spain). BMC Cancer 11: 192.
11. Lee S, Zelen M (1998) Scheduling periodic examinations for the early detection of disease: applications to breast cancer. J Am Stat Assoc (93): 1271-1281. (Pubitemid 128385542)
12. Lee S, Zelen M (2006) A stochastic model for predicting the mortality of breast cancer. J Natl Cancer Inst Monogr (36): 79-86.
13. Lee SJ, Zelen M (2008) Mortality modeling of early detection programs. Biometrics 64: 386-395. (Pubitemid 351691917)
14. Vilaprinyo E, Gispert R, Martinez-Alonso M, Carles M, Pla R, et al. (2008) Competing risks to breast cancer mortality in Catalonia. BMC Cancer 8: 331.
15. Vilaprinyo E, Rue M, Marcos-Gragera R, Martinez-Alonso M (2009) Estimation of age- and stage- specific Catalan breast cancer survival functions using US and Catalan survival data. BMC Cancer 9: 98.
16. Rue M, Vilaprinyo E, Lee S, Martinez-Alonso M, Carles M, et al. (2009) Effectiveness of early detection on breast cancer mortality reduction in Catalonia (Spain). BMC Cancer 9: 326.
17. Martinez-Alonso M, Vilaprinyo E, Marcos-Gragera R, Rue M (2010) Breast cancer incidence and overdiagnosis in Catalonia (Spain). Breast Cancer Res 12: R58.
18. Zelen M, Feinleib M (1969) On the theory of screening for chronic diseases. Biometrika 56: 601-614.
19. Day NE, Walter SD (1984) Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 40: 1-14.
20. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, et al. (2008) Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 148: 337-347. (Pubitemid 351665464)
21. American College of Radiology (2003) The American College of Radiology Breast Imaging Reporting and Data System (BI-RADS). American College of Radiology, Reston (VA).
22. Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, et al. (2006) Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 98: 1204-1214. (Pubitemid 44390991)
23. Lidgren M, Wilking N, Jonsson B, Rehnberg C (2007) Health related quality of life in different states of breast cancer. Qual Life Res 16: 1073-1081. (Pubitemid 47174889)
24. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L (2007) Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 8: 1129-1138. (Pubitemid 350182969)
25. de Koning HJ, Draisma G, Fracheboud J, de Bruijn A (2006) Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data. Breast Cancer Res 8: 202.
26. Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, et al. (2009) Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Cancer Causes Control (21): 275-282.
27. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP (2006) Rate of overdiagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ 332: 689-692.
28. Zahl PH, Maehlen J, Welch HG (2008) The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 168: 2311-6.
29. Rue M, Carles M, Vilaprinyo E, Martinez-Alonso M, Espinas JA, et al. (2008) Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain). BMC Cancer 8: 336.
30. Perez MJ, Gregori A, Carles M, Gispert R, Martinez-Alonso M, et al. (2010) The evolution of breast cancer mortality and the dissemination of mammography in Catalonia: an analysis by health region. Rev Esp Salud Publica 84: 691-703.
31. Erbas B, Amos A, Fletcher A, Kavanagh AM, Gertig DM (2004) Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening? Cancer Epidemiol Biomarkers Prev 13: 1569-1573. (Pubitemid 39331876)
32. Lopez Bastida J, Oliva J, Antonanzas F, Garcia-Altes A, Gisbert R, et al. (2010) A proposed guideline for economic evaluation of health technologies. Gac Sanit 24: 154-170.
33. Gotzsche PC, Jorgensen K (2013) Screening for breast cancer with mammography. Cochrane Database Syst Rev 6: CD001877.
34. Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380: 1778-1786.
35. Paci E, EuroscreenWorking Group (2012) Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 19 Suppl 1: 5-13.
36. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
37. Izquierdo A, Gispert R, Saladie F, Espinas JA (2008) Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985-2019: Breast cancer. Med Clin (Barc) 131 Suppl 1: 50-52.
38. Ayer T, Alagoz O, Stout N (2012) A POMDP Approach to Personalize Mammography Screening Decisions. Operations Research 60: 1019-1034.
39. McCann J, Britton PD, Warren RM, Hunnam G (2001) Radiological peer review of interval cancers in the East Anglian breast screening programme: what are we missing? East Anglian Breast Screening Programme. J Med Screen 8: 77-85. (Pubitemid 32664888)
40. Domingo L, Sala M, Servitja S, Corominas JM, Ferrer F, et al. (2010) Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain. Cancer Causes Control 21: 1155-1164.
41. Kirsh VA, Chiarelli AM, Edwards SA, O'Malley FP, Shumak RS, et al. (2011) Tumor characteristics associated with mammographic detection of breast cancer in the ontario breast screening program. J Natl Cancer Inst 103: 942-950.
42. Kerlikowske K, Carney PA, Geller B, Mandelson MT, Taplin SH, et al. (2000) Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med 133: 855-863.
43. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, et al. (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138: 168-175. (Pubitemid 36231622)
44. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, et al. (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353: 1773-1783. (Pubitemid 41549889)
45. Karssemeijer N, Bluekens AM, Beijerinck D, Deurenberg JJ, Beekman M, et al. (2009) Breast cancer screening results 5 years after introduction of digital mammography in a population-based screening program. Radiology 253: 353-358.
46. Mandelblatt JS, Stout N, Trentham-Dietz A (2011) To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer? Ann Intern Med 155: 58-60.
47. National Health Service (no date) The PROCAS Study website. Available: http://www.uhsm.nhs.uk/research/Pages/PROCASstudy.aspx. Accessed 2013 Dec 21.
48. Karolinska Institutet (no date) Karolinska Mammography Project for Risk Prediction of Breast Cancer website. Available: http://karmastudy.org/. Accessed 2013 Dec 21.
49. Darabi H, Czene K, Zhao W, Liu J, Hall P, et al. (2012) Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Breast Cancer Res 14: R25.
50. Li J, Szekely L, Eriksson L, Heddson B, Sundbom A, et al. (2012) High-throughput mammographicdensity measurement: a tool for risk prediction of breast cancer. Breast Cancer Res 14: R114.
51. National Cancer Institute (no date) Cancer Control Research website. Available: http://cancercontrol.cancer.gov/grants/abstract.asp?applid = 8223497. Accessed 2013 Dec 21.